Dendrite Clinical Systems and the Society for Cardiothoracic surgery (SCTS) have published a new report that demonstrates importance collecting and analysing data from thoracic surgery. The report states that a large increase in thoracoscopic (VATS) resections is responsible for most of the recent increase in lung cancer surgery, rising from 749 cases in 2010-2011 to 2,753 in 2014-2015, an increase of more than 3.5 times.
Dendrite Clinical Systems is to install its Intellect System to track outcomes of cardiothoracic surgery at St George’s Hospital, Tooting, London, UK. The company’s data capture software currently supports approximately 85% of cardiac units in the UK. 
Dendrite Clinical Systems and Waldenström’s Macroglobulinaemia United Kingdom Charity have published the First UK Waldenström’s Macroglobulinaemia Registry Report 2018 – the first report of its kind in the world. 
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 38 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems and the British Society for Allergy & Clinical Immunology (BSACI) have launched the British Registry for Immunotherapy (BRIT), a web-based patient registry that records immunotherapy treatment of patients under the care of BSACI consultants practicing in the UK.
Dendrite Clinical Systems, under the auspices of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), has published the Fourth IFSO Global Registry Report (2018) at the federation’s XXIII World Congress in Dubai, UAE. The latest report features data from more than 50 countries on over 394,000 operations including baseline obesity-related disease, operation types, operative outcomes and disease status after bariatric/metabolic surgery.
Dendrite publishes first ever national bariatric and metabolic surgery report in the Arabian Gulf region
Dendrite Clinical Systems and The State of Kuwait Ministry of Health, in conjunction with Bader Sultan & Brothers Company, are pleased to announce the publication of the First Kuwait National Bariatric Registry Report 2019, the first ever national report on bariatric and metabolic surgery in the Arabian Gulf region. This inaugural report, which includes 3,302 bariatric surgery cases, contains data on baseline obesity-related disease, operation types, operative outcomes and disease status after bariatric surgery in Kuwait.
“It is with great pleasure that I commend this First Report of the National Bariatric Surgery Database made available by Dendrite Clinical Systems. This National Bariatric Surgery Database initiative is the first of its kind in the State of Kuwait,” His Excellency, Dr Basel Hamoud Al-Sabah, Minister of Health, Kuwait, writes in the report. “There are only a few countries in the world that have the capability to have a unified registry under one network. Many countries maintain hospital-based registries. Even fewer countries have national databases…Therefore, we are very proud that we now have a national registry established under one network for all the government hospitals in Kuwait.
The Kuwait National Bariatric Surgical Registry utilised Dendrite’s “Intellect Web” national registry software to facilitate on-line data entry. The Registry is accessed using a range of modern html-5 compatible web browsers, allowing registrants to enter data without the need to install additional software or perform any complex system configurations.
The Kuwait National Bariatric Registry currently comprises data being submitted from six public by 63 surgeons and collected data from 3,302 cases. The “Intellect Web” software recorded data on patient demographics, procedure data, outcomes, as well as information ten obesity-related conditions including: type 2 diabetes, back or leg pain, depression, impaired functional status, gastro-oesophageal reflux, raised blood pressure, dyslipidaemia, liver disease, sleep apnoea and increased risk of deep vein thrombosis or pulmonary embolism.
“We are delighted to publish this first report and I would like to thank all the contributors for submitting their data,” said Dr Peter Walton, Managing Director of Dendrite. “This report clearly demonstrates the safety and effectiveness of bariatric and metabolic surgery for treating patients with obesity in Kuwait. I hope this report will be the first in a series of ground-breaking reports that will record and analyse clinical data, and help improve patient outcomes.”
